Bloomage BioTechnology Corporation Limited (688363.SS)
CNY 47.93
(-0.15%)
CNY 47.93
(-0.15%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.28 Billion CNY | -35.92% |
| 2022 | 1.99 Billion CNY | 10.96% |
| 2021 | 1.8 Billion CNY | 157.78% |
| 2020 | 698.75 Million CNY | 65.54% |
| 2019 | 422.1 Million CNY | 19.39% |
| 2018 | 353.56 Million CNY | 44.1% |
| 2017 | 245.35 Million CNY | -42.07% |
| 2016 | 423.52 Million CNY | -57.26% |
| 2015 | 990.97 Million CNY | 365.38% |
| 2014 | 212.93 Million CNY | 4.4% |
| 2013 | 203.96 Million CNY | 109.65% |
| 2012 | 97.28 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 1.63 Billion CNY | 2.54% |
| 2024 Q1 | 1.18 Billion CNY | -7.24% |
| 2024 Q2 | 1.59 Billion CNY | 34.19% |
| 2023 Q3 | 1.37 Billion CNY | -5.79% |
| 2023 FY | 1.28 Billion CNY | -35.92% |
| 2023 Q2 | 1.45 Billion CNY | -3.96% |
| 2023 Q1 | 1.52 Billion CNY | -23.95% |
| 2023 Q4 | 1.28 Billion CNY | -6.87% |
| 2022 Q3 | 1.61 Billion CNY | -8.57% |
| 2022 Q2 | 1.76 Billion CNY | 25.74% |
| 2022 Q1 | 1.4 Billion CNY | -22.14% |
| 2022 FY | 1.99 Billion CNY | 10.96% |
| 2022 Q4 | 1.99 Billion CNY | 23.96% |
| 2021 Q1 | 876.11 Million CNY | 25.38% |
| 2021 Q3 | 1.19 Billion CNY | -9.01% |
| 2021 Q4 | 1.8 Billion CNY | 50.95% |
| 2021 FY | 1.8 Billion CNY | 157.78% |
| 2021 Q2 | 1.31 Billion CNY | 49.69% |
| 2020 Q2 | 697.43 Million CNY | 85.76% |
| 2020 FY | 698.75 Million CNY | 65.54% |
| 2020 Q3 | 492.27 Million CNY | -29.42% |
| 2020 Q1 | 375.45 Million CNY | -11.05% |
| 2020 Q4 | 698.75 Million CNY | 41.94% |
| 2019 FY | 422.1 Million CNY | 19.39% |
| 2019 Q1 | 277.19 Million CNY | -21.6% |
| 2019 Q2 | 367.05 Million CNY | 32.42% |
| 2019 Q3 | 362.21 Million CNY | -1.32% |
| 2019 Q4 | 422.1 Million CNY | 16.54% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | 353.56 Million CNY | 44.1% |
| 2018 Q4 | 353.56 Million CNY | 0.0% |
| 2017 Q1 | 799.89 Million CNY | -7.74% |
| 2017 Q2 | 799.89 Million CNY | 0.0% |
| 2017 FY | 245.35 Million CNY | -42.07% |
| 2016 Q2 | 764.38 Million CNY | 0.0% |
| 2016 Q4 | 867.02 Million CNY | 0.0% |
| 2016 Q3 | 867.02 Million CNY | 13.43% |
| 2016 Q1 | 764.38 Million CNY | -24.11% |
| 2016 FY | 423.52 Million CNY | -57.26% |
| 2015 Q2 | 396.32 Million CNY | 0.0% |
| 2015 Q3 | 1 Billion CNY | 154.14% |
| 2015 Q4 | 1 Billion CNY | 0.0% |
| 2015 Q1 | 396.32 Million CNY | 86.12% |
| 2015 FY | 990.97 Million CNY | 365.38% |
| 2014 FY | 212.93 Million CNY | 4.4% |
| 2014 Q3 | 212.93 Million CNY | -15.32% |
| 2014 Q1 | 251.45 Million CNY | 23.28% |
| 2014 Q2 | 251.45 Million CNY | 0.0% |
| 2014 Q4 | 212.93 Million CNY | 0.0% |
| 2013 FY | 203.96 Million CNY | 109.65% |
| 2013 Q2 | 207.49 Million CNY | 0.0% |
| 2013 Q1 | 207.49 Million CNY | 113.29% |
| 2013 Q4 | 203.96 Million CNY | 0.0% |
| 2013 Q3 | 203.96 Million CNY | -1.71% |
| 2012 FY | 97.28 Million CNY | 0.0% |
| 2012 Q4 | 97.28 Million CNY | 0.0% |
| 2012 Q3 | 97.28 Million CNY | 0.0% |